Milind Deshpande Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Milind Deshpande.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Milind Deshpande. Milind Deshpande is Chief Executive Officer in ACHILLION PHARMACEUTICALS INC ($ACHN) and EVP and CSO in ACHILLION PHARMACEUTICALS INC ($ACHN) and Pres R&D and CSO in ACHILLION PHARMACEUTICALS INC ($ACHN) and President and CEO in ACHILLION PHARMACEUTICALS INC ($ACHN) and President and CSO in ACHILLION PHARMACEUTICALS INC ($ACHN) and President of R&D and CSO in ACHILLION PHARMACEUTICALS INC ($ACHN) and SVP and CSO in ACHILLION PHARMACEUTICALS INC ($ACHN) and Director in Spero Therapeutics, Inc. ($SPRO).
Latest Insider Trading Transactions of Milind Deshpande
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 06 2021 | SPRO | Spero Therapeutics ... | Deshpande Milind | Director | Option Exercise | A | 17.93 | 2,629 | 47,138 | 2,629 | |
| Oct 27 2020 | SPRO | Spero Therapeutics ... | Deshpande Milind | Director | Option Exercise | A | 13.52 | 7,500 | 101,400 | 7,500 | |
| Jan 06 2020 | SPRO | Spero Therapeutics ... | Deshpande Milind | Director | Option Exercise | A | 9.87 | 5,408 | 53,377 | 5,408 | |
| Jun 05 2019 | SPRO | Spero Therapeutics ... | Deshpande Milind | Director | Option Exercise | A | 10.67 | 6,073 | 64,799 | 6,073 | |
| Jun 06 2018 | SPRO | Spero Therapeutics ... | Deshpande Milind | Director | Option Exercise | A | 11.54 | 6,073 | 70,082 | 6,073 | |
| Feb 13 2018 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | Chief Executive Off ... | Option Exercise | A | 2.90 | 640,000 | 1,856,000 | 640,000 | |
| Jan 19 2017 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | Chief Executive Off ... | Option Exercise | A | 4.11 | 458,000 | 1,882,380 | 458,000 | |
| Dec 05 2016 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | Chief Executive Off ... | Buy | P | 4.06 | 2,500 | 10,150 | 2,500 | 0 to 2.5 K |
| Jan 22 2016 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | Chief Executive Off ... | Option Exercise | A | 7.61 | 400,000 | 3,044,000 | 400,000 | |
| Jan 23 2015 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CEO | Option Exercise | M | 3.02 | 100,000 | 302,000 | 300,000 | |
| Jan 23 2015 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CEO | Sell | S | 15.00 | 100,000 | 1,500,000 | 0 | 100 K to 0 (-100.00 %) |
| Jan 23 2015 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CEO | Buy | M | 3.02 | 100,000 | 302,000 | 100,000 | 0 to 100 K |
| Dec 04 2014 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CEO | Option Exercise | A | 13.24 | 345,000 | 4,567,800 | 345,000 | |
| Aug 19 2014 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CEO | Option Exercise | M | 3.10 | 124,424 | 385,714 | 75,576 | |
| Aug 19 2014 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CEO | Option Exercise | M | 3.28 | 60,000 | 196,800 | 0 | |
| Aug 19 2014 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CEO | Option Exercise | M | 1.05 | 15,950 | 16,748 | 0 | |
| Aug 19 2014 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CEO | Option Exercise | M | 4.00 | 16,250 | 65,000 | 0 | |
| Aug 19 2014 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CEO | Sell | S | 10.00 | 124,424 | 1,244,240 | 0 | 124.4 K to 0 (-100.00 %) |
| Aug 19 2014 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CEO | Buy | M | 3.10 | 124,424 | 385,714 | 124,424 | 0 to 124.4 K |
| Aug 19 2014 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CEO | Sell | S | 10.00 | 60,000 | 600,000 | 0 | 60 K to 0 (-100.00 %) |
| Aug 19 2014 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CEO | Buy | M | 3.28 | 60,000 | 196,800 | 60,000 | 0 to 60 K |
| Aug 19 2014 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CEO | Sell | S | 10.00 | 15,950 | 159,500 | 0 | 16 K to 0 (-100.00 %) |
| Aug 19 2014 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CEO | Buy | M | 1.05 | 15,950 | 16,748 | 15,950 | 0 to 16 K |
| Aug 19 2014 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CEO | Sell | S | 10.00 | 16,250 | 162,500 | 0 | 16.3 K to 0 (-100.00 %) |
| Aug 19 2014 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CEO | Buy | M | 4.00 | 16,250 | 65,000 | 16,250 | 0 to 16.3 K |
| May 23 2014 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CEO | Option Exercise | A | 3.02 | 250,000 | 755,000 | 400,000 | |
| May 23 2014 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CEO | Option Exercise | J | 3.02 | 250,000 | 755,000 | 150,000 | |
| Dec 19 2013 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CEO | Option Exercise | A | 3.02 | 400,000 | 1,208,000 | 400,000 | |
| May 30 2013 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CEO | Option Exercise | A | 7.59 | 600,000 | 4,554,000 | 600,000 | |
| Dec 20 2012 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President of R&D an ... | Option Exercise | A | 8.64 | 145,000 | 1,252,800 | 145,000 | |
| Mar 19 2012 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CSO | Option Exercise | M | 1.05 | 5,312 | 5,578 | 15,950 | |
| Mar 19 2012 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CSO | Sell | S | 10.70 | 5,312 | 56,838 | 0 | 5.3 K to 0 (-100.00 %) |
| Mar 19 2012 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CSO | Buy | M | 1.05 | 5,312 | 5,578 | 5,312 | 0 to 5.3 K |
| Jan 11 2012 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CSO | Option Exercise | M | 1.05 | 10,625 | 11,156 | 21,262 | |
| Jan 11 2012 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CSO | Sell | S | 9.34 | 10,625 | 99,238 | 0 | 10.6 K to 0 (-100.00 %) |
| Jan 11 2012 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CSO | Buy | M | 1.05 | 10,625 | 11,156 | 10,625 | 0 to 10.6 K |
| Dec 14 2011 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President of R&D an ... | Option Exercise | A | 7.59 | 100,000 | 759,000 | 100,000 | |
| Jun 30 2011 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CSO | Option Exercise | M | 1.05 | 5,313 | 5,579 | 31,887 | |
| Jun 30 2011 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CSO | Option Exercise | M | 1.60 | 13,125 | 21,000 | 0 | |
| Jun 30 2011 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CSO | Option Exercise | M | 1.60 | 18,750 | 30,000 | 0 | |
| Jun 30 2011 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CSO | Option Exercise | M | 1.60 | 12,500 | 20,000 | 0 | |
| Jun 30 2011 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CSO | Sell | S | 8.50 | 5,313 | 45,161 | 0 | 5.3 K to 0 (-100.00 %) |
| Jun 30 2011 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CSO | Sell | S | 8.05 | 44,375 | 357,379 | 5,313 | 49.7 K to 5.3 K (-89.31 %) |
| Jun 30 2011 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CSO | Buy | M | 1.05 | 5,313 | 5,579 | 49,688 | 44.4 K to 49.7 K (+11.97 %) |
| Jun 30 2011 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CSO | Buy | M | 1.60 | 13,125 | 21,000 | 44,375 | 31.3 K to 44.4 K (+42.00 %) |
| Jun 30 2011 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CSO | Buy | M | 1.60 | 18,750 | 30,000 | 31,250 | 12.5 K to 31.3 K (+150.00 %) |
| Jun 30 2011 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CSO | Buy | M | 1.60 | 12,500 | 20,000 | 12,500 | 0 to 12.5 K |
| Jun 24 2011 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CSO | Sell | S | 7.50 | 4,825 | 36,204 | 0 | 4.8 K to 0 (-100.00 %) |
| Jun 24 2011 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President and CSO | Sell | S | 7.51 | 10,800 | 81,068 | 4,825 | 15.6 K to 4.8 K (-69.12 %) |
| May 31 2011 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | Pres R&D and CSO | Option Exercise | M | 1.05 | 47,800 | 50,190 | 37,200 | |
| May 31 2011 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | Pres R&D and CSO | Sell | S | 7.01 | 47,800 | 335,269 | 15,625 | 63.4 K to 15.6 K (-75.36 %) |
| May 31 2011 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | Pres R&D and CSO | Buy | M | 1.05 | 47,800 | 50,190 | 63,425 | 15.6 K to 63.4 K (+305.92 %) |
| Dec 20 2010 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | President of R&D an ... | Option Exercise | A | 3.10 | 200,000 | 620,000 | 200,000 | |
| Dec 22 2009 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | EVP and CSO | Option Exercise | A | 3.28 | 60,000 | 196,800 | 60,000 | |
| Dec 17 2008 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | EVP and CSO | Option Exercise | A | 1.05 | 85,000 | 89,250 | 85,000 | |
| Dec 18 2007 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | EVP and CSO | Option Exercise | A | 4.82 | 60,000 | 289,200 | 60,000 | |
| Jun 08 2007 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | EVP and CSO | Option Exercise | A | 5.41 | 47,900 | 259,139 | 47,900 | |
| Dec 26 2006 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | SVP and CSO | Option Exercise | A | 14.75 | 46,000 | 678,500 | 46,000 |
Page: 1